SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Plandaí Biotechnology, Inc. (PLPL) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 21/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PLPL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.14 |
$265.75K |
$-15.61M |
-5872.9% |
| 2014 |
$-0.08 |
$92.9K |
$-9.58M |
-10314.5% |
| 2015 |
$-0.03 |
$298.49K |
$-4.38M |
-1467% |
| 2016 |
$-0.02 |
$411.99K |
$-4.01M |
-972.8% |
| 2019 |
$0.00 |
$0.00 |
$-83.48K |
- |
| 2020 |
$0.00 |
$0.00 |
$-397K |
- |
| 2021 |
$0.00 |
$0.00 |
$6.82M |
- |
| 2022 |
$0.00 |
$0.00 |
$-19.8M |
- |
| 2023 |
$0.00 |
$0.00 |
$16.03M |
- |
| 2024 |
$0.00 |
$0.00 |
$-2.45K |
- |
